Shots:Eli Lilly has entered into a global licensing & multi-target research collaboration with Creyon Bio to identify, develop & market novel RNA-targeted oligonucleotide therapies for Lilly’s named targets using Creyon’s AI-powered Oligo Engineering EngineAs per the deal, Lilly will get exclusive rights of lead candidates & handle further research, development & marketing upon…
